Related references
Note: Only part of the references are listed.Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo
Chris Zhiyi Zhang et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Antitumor Activity of Artemisinin and Its Derivatives: From a Well-Known Antimalarial Agent to a Potential Anticancer Drug
Maria P. Crespo-Ortiz et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Hypoxia modulates the effect of dihydroartemisinin on endothelial cells
S. D'Alessandro et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway
Shuang-Jia Wang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet et al.
NATURE (2011)
Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells
Jin-Jian Lu et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro
Hui-Jun Zhou et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Animal models of choroidal and retinal neovascularization
Hans E. Grossniklaus et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2010)
Constitutive NF-κB Activation in Colorectal Carcinoma Plays a Key Role in Angiogenesis, Promoting Tumor Growth
Kei Sakamoto et al.
CLINICAL CANCER RESEARCH (2009)
CXCL8/IL8 Stimulates Vascular Endothelial Growth Factor (VEGF) Expression and the Autocrine Activation of VEGFR2 in Endothelial Cells by Activating NFκB through the CBM (Carma3/Bcl10/Malt1) Complex
Daniel Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
IκB Kinase-α Regulates Endothelial Cell Motility and Tumor Angiogenesis
Laura M. DeBusk et al.
CANCER RESEARCH (2008)
Epidermal growth factor (EGF) activates nuclear factor-κB through IκBα kinase-independent but EGF receptor-kinase dependent tyrosine 42 phosphorylation of IκBα
G. Sethi et al.
ONCOGENE (2007)
Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells
Hui-Jun Zhou et al.
VASCULAR PHARMACOLOGY (2007)
NF-κB inhibitors for the treatment of inflammatory diseases and cancer
Marco A. Calzado et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Induction of apoptosis and inhibition of cell migration and tube-like formation by dihydroartemisinin in murine lymphatic endothelial cells
Jun Wang et al.
PHARMACOLOGY (2007)
In vivo and in vitro investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos
Monica Longo et al.
REPRODUCTIVE TOXICOLOGY (2006)
Tumor metastasis: mechanistic insights and clinical challenges
Patricia S. Steeg
NATURE MEDICINE (2006)
Angiogenesis as a therapeutic target
N Ferrara et al.
NATURE (2005)
Angiogenesis in life, disease and medicine
P Carmeliet
NATURE (2005)
Endothelial cells and VEGF in vascular development
L Coultas et al.
NATURE (2005)
Epidermal growth factor activates nuclear factor-κB in human proximal tubule cells
U Häussler et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Antimalarial dihydroartemisinin also inhibits angiogenesis
HH Chen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
Artemisinin derivatives: toxic for laboratory animals, safe for humans?
T Gordi et al.
TOXICOLOGY LETTERS (2004)
Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate
R Dell'Eva et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Apoptosis of human umbilical vein endothelial cells induced by artesunate
GD Wu et al.
VASCULAR PHARMACOLOGY (2004)
Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro
HH Chen et al.
PHARMACOLOGICAL RESEARCH (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-κB to protect endothelial cells from tumor necrosis factor-α-mediated apoptosis
S Brouard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Inhibition of NF-κB activity by thalidomide through suppression of IκB kinase activity
JA Keifer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Transforming growth factor-β1-mediated inhibition of the flk-1/KDR gene is mediated by a 5′-untranslated region palindromic GATA site
T Minami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
